GVHD: biology matters

• Autor: Ferrara, James L M ; Chaudhry, Mohammed S
• Assuntos: Reining in Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation
• É parte de: Hematology, 2018-11, Vol.2018 (1), p.221-227
• Notas: ObjectType-Article-2
  SourceType-Scholarly Journals-1
  ObjectType-Feature-3
  content type line 23
  ObjectType-Review-1
  This article was selected by the Blood Advances and Hematology 2018 American Society of Hematology Education Program editors for concurrent submission to Blood Advances and Hematology 2018. It is reprinted from Blood Advances 2018, Volume 2.
  Off-label drug use: None disclosed.
  Conflicts-of-interest disclosure: J.L.M.F. is a coinventor on a graft-versus-host disease biomarker patent. M.S.C declares no competing financial interest.
  
• Descrição: Acute graft-versus-host disease (GVHD) targets the crypts in the gastrointestinal (GI) tract that are responsible for the self-renewal of the intestinal mucosa. Recent advances in the identification and culture of intestinal stem cells have improved our understanding of the interactions between the microbiome and the immune system (both innate and adaptive) that are key to the pathophysiology of GVHD. The identification of serum biomarkers that best predict long-term GVHD outcomes derive from the GI tract and have focused attention on cellular elements that act as shields against GVHD as well as its targets. These biomarkers have illuminated new mechanisms of crypt biology and provided insights that should prove useful both in the design of clinical trials and as guides to GVHD prevention and treatment.
  
• Editor: United States: American Society of Hematology
  
• Idioma: Inglês